CONCERT PHARMACEUTICALS INC's ticker is CNCE and the CUSIP is 206022105. A total of 80 filers reported holding CONCERT PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is 0.71 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $414,640 | -12.9% | 71,000 | 0.0% | 0.15% | -21.9% |
| Q3 2022 | $476,000 | +64.1% | 71,000 | +2.9% | 0.19% | +68.4% |
| Q2 2022 | $290,000 | +87.1% | 69,000 | +50.0% | 0.11% | +132.7% |
| Q1 2022 | $155,000 | +6.9% | 46,000 | 0.0% | 0.05% | 0.0% |
| Q4 2021 | $145,000 | -3.3% | 46,000 | 0.0% | 0.05% | -31.9% |
| Q3 2021 | $150,000 | +2.7% | 46,000 | +33.3% | 0.07% | +26.3% |
| Q2 2021 | $146,000 | – | 34,500 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| L1 Capital Pty Ltd | 1,149,120 | $14,559,000 | 2.72% |
| Corriente Advisors, LLC | 680,000 | $8,595,000 | 2.05% |
| ACUTA CAPITAL PARTNERS, LLC | 537,500 | $6,794,000 | 1.85% |
| INGALLS & SNYDER LLC | 1,362,203 | $17,218,000 | 0.85% |
| Kensington Investment Counsel, LLC | 75,533 | $955,000 | 0.79% |
| SPHERA FUNDS MANAGEMENT LTD. | 384,039 | $4,854,000 | 0.43% |
| Opaleye Management Inc. | 254,000 | $3,211,000 | 0.42% |
| RA Capital Management | 1,823,520 | $23,049,000 | 0.32% |
| Perceptive Advisors | 2,150,641 | $27,184,000 | 0.29% |
| Parkman Healthcare Partners LLC | 50,290 | $636,000 | 0.16% |